Division of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
Urol Clin North Am. 2013 Feb;40(1):129-33. doi: 10.1016/j.ucl.2012.09.010. Epub 2012 Oct 22.
Kidney stone disease is rising in prevalence in the United States and abroad, and the cost burden of this condition is substantial. Although cost-effectiveness considerations are typically made by policymakers, individual practitioners have become increasingly involved in these discussions, to affect the rising costs of care and to assert control of treatment options. This article reviews existing literature regarding the cost-effectiveness of medical and surgical treatments for stone disease and identifies areas in which additional investigation is needed.
肾结石疾病在美国和国外的发病率正在上升,这种疾病的负担也很大。尽管决策者通常会考虑成本效益,但个体从业者也越来越多地参与到这些讨论中,以控制不断上升的治疗成本,并对治疗方案进行控制。本文回顾了关于结石病的医学和手术治疗的成本效益的现有文献,并确定了需要进一步研究的领域。